Canaan Partners is an early-stage venture capital firm founded in 1987 and based in San Francisco, California, with additional offices in Westport, Connecticut, Israel, and India. The firm specializes in investing in entrepreneurs with innovative ideas across various sectors, primarily focusing on technology and healthcare. Canaan manages over $5 billion in capital and has invested in more than 250 companies, achieving over 190 exits. Its investment strategy encompasses a range of sectors, including fintech, enterprise/cloud, digital health, biopharma, medical technology, and frontier tech, with funding capabilities from $1 million to $20 million. The firm is recognized for its experienced team of investment professionals who leverage their extensive backgrounds in technology, infrastructure, communications, and life sciences to support promising ventures at various stages of development.
Cynomi offers an AI-powered, automated virtual Chief Information Security Officer (vCISO) platform designed to assist Managed Security Service Providers (MSSPs) and consulting firms in delivering vCISO services efficiently and at scale. Founded in 2021 and based in London, the company’s multi-tenant platform automatically generates essential components for vCISO services, including risk and compliance assessments, customized security policies, and actionable remediation plans with prioritized tasks. Additionally, it provides task management tools and customer-facing reports, ensuring that organizations can maintain optimal cybersecurity posture and regulatory compliance. Cynomi's solution enables businesses to enhance their security measures without the need to expand existing resources.
AttoTude
Series B in 2025
AttoTude is a pioneer in the creation of novel connection technology for AI and hyperscale data center applications. The company is developing a distinctive technology for high-speed data networking that will overcome the constraints of current interconnect systems, including considerable increases in bandwidth, power dissipation, reliability, and cost.
Halda Therapeutics
Series B in 2024
Halda Therapeutics is a research-stage drug discovery company focused on developing next-generation precision medicines. The company utilizes a novel therapeutic modality aimed at creating treatments that can address various disease states. By modifying disease-causing pathways, Halda Therapeutics seeks to enable healthcare providers to offer tailored therapies to patients, enhancing the effectiveness of treatment based on individual patient needs.
Greywolf Therapeutics
Series B in 2024
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This approach marks a fundamental shift in how we treat people living with autoimmune disorders, cancers and infectious diseases.
Nivoda
Series B in 2024
Nivoda Limited is a business-to-business online marketplace based in London, with an additional office in Hong Kong, that specializes in the buying and selling of diamonds and jewelry. Founded in 2017, Nivoda simplifies the global jewelry trade by providing a platform that connects jewelry businesses with verified suppliers, allowing them to browse a wide selection of diamonds and gemstones. The marketplace enables users to purchase goods efficiently from anywhere in the world through a single checkout process, helping clients source diamonds at competitive prices while minimizing logistical hurdles and additional costs associated with international purchases. Nivoda's aim is to enhance profits and accelerate growth for jewelry businesses by streamlining the sourcing process.
Quantum Circuits
Venture Round in 2024
Quantum Circuits, Inc. specializes in the development and manufacture of quantum computers utilizing superconducting devices. Founded in 2015 and located in New Haven, Connecticut, the company aims to innovate in the field of quantum computing by delivering full-stack systems that efficiently scale. Led by Dr. Robert Schoelkopf, a prominent figure in quantum science, Quantum Circuits employs a unique dual-rail quantum qubit design that incorporates built-in hardware error detection and conversion. This approach allows for a highly scalable error-corrected system, requiring significantly fewer physical qubits per logical qubit and providing a more efficient pathway to fault-tolerant quantum computing. By focusing on solid-state quantum bits, the company enables clients to perform error-free computations, thereby accelerating research and advancing the practical applications of quantum technology.
Qlaris Bio
Series B in 2024
Qlaris Bio, Inc. is a clinical-stage biotechnology company based in Wellesley, Massachusetts, focused on developing innovative therapies for serious ophthalmic diseases. Founded in 2017, the company is working on QLS-101, a therapy aimed at reducing intraocular pressure, a critical factor in conditions such as glaucoma. Qlaris Bio explores novel mechanisms to address episcleral venous pressure, which significantly contributes to intraocular pressure, thereby aiming to mitigate the risk of blindness associated with both Primary Open Angle Glaucoma and Normal Tension Glaucoma. The company also targets high unmet medical needs in pediatric rare diseases related to intraocular pressure disturbances, where effective treatment options are currently limited.
Alterome Therapeutics
Series B in 2024
Alterome Therapeutics is a biotechnology company focused on precision oncology, dedicated to developing targeted therapeutics that specifically address validated oncogenic drivers in cancer. The firm aims to discover and create alteration-specific therapies that provide hope and improved treatment options for individuals affected by cancer. By concentrating on high-value oncogenic alterations, Alterome Therapeutics seeks to enhance the effectiveness of cancer treatments and support healthcare providers in their efforts to combat the disease.
Lily AI
Series B in 2024
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Nocion Therapeutics
Series B in 2024
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.
Acesion Pharma
Series B in 2023
Acesion Pharma ApS is a biotech company based in Copenhagen, Denmark, founded in 2011. The company specializes in the development of medical drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Acesion Pharma focuses on creating SK channel inhibitors, which target specific ion channels in heart cells that are essential for generating the electrical signals that regulate heart rhythm. By inhibiting these channels, the company aims to provide safe and tolerable chronic treatments that prevent the recurrence of AF and support the maintenance of a normal heart rhythm.
Greywolf Therapeutics
Series B in 2023
Many cancers and other diseases are caused, or resist treatment, because T cells can't recognize or target cells correctly. We're progressing first-in-class antigen modulators through the clinic, developed to treat disease by controlling T cell activation. Our technology modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. This approach marks a fundamental shift in how we treat people living with autoimmune disorders, cancers and infectious diseases.
WorkMotion
Series B in 2022
WorkMotion is a global HR platform headquartered in Berlin, Germany, that facilitates the hiring and onboarding of international employees. Founded in 2020, the company offers a cloud-based workforce management platform that allows employers to recruit and manage employees worldwide without the need to establish legal entities in foreign countries. WorkMotion streamlines the hiring processes, consolidates global payroll accounting, and supports the management of freelancers, enabling organizations to efficiently hire and pay remote employees from around the globe.
Appsmith
Series B in 2022
Appsmith is a developer of an open-source low-code application platform established in mid-2019. The platform enables developers to efficiently build, deploy, and manage custom internal applications, particularly focusing on CRUD functionalities. With over 5 million downloads and usage among more than 1,000 enterprises across over 100 countries, Appsmith aims to simplify the development of internal tools by streamlining operations, automating processes, and facilitating the integration of various applications and data. Additionally, the platform enhances legacy applications by allowing developers to incorporate new features, all while maintaining enterprise-grade security and governance.
Lily AI
Venture Round in 2022
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.
Dusty Robotics
Series B in 2022
Dusty Robotics, Inc. specializes in providing automated layout services for the construction industry through its innovative robot-powered tools. Founded in 2018 and based in Mountain View, California, the company offers the FieldPrinter, which translates digital building information modeling (BIM) designs into accurate, constructible layouts directly on construction-site floors. By synchronizing BIM information with on-site requirements, Dusty Robotics eliminates manual steps in the workflow, enhancing efficiency and reducing waste in labor and materials. The company serves a diverse range of clients, including owners, general contractors, subcontractors, and builders, aiming to streamline the design-build-operate lifecycle in construction projects.
Lev
Series B in 2022
Lev Inc is a New York-based company founded in 2019 that specializes in financial services, particularly in lending and capital management solutions for commercial real estate transactions. The company has developed a technology platform designed to digitize these transactions, utilizing machine learning and artificial intelligence to analyze historical data and lender activity. This innovative approach allows Lev to identify optimal financing scenarios and connect clients with appropriate lenders. Additionally, the platform facilitates communication and negotiation on behalf of clients, streamlining the process of securing financing for property transactions.
Hermeus
Series B in 2022
Hermeus is developing Mach 5 aircraft to speed up the global transportation network. Mach 5 flight is not just supersonic, it's hypersonic. At these speeds, a flight from New York to London is 90 minutes, rather than 7 hours. Its aircraft massively reduces flight times and increases safety for the long haul and business class air travel, enabling businesses to operate with minimal changes to current aviation infrastructure. The company was founded in 2018 and headquartered in Atlanta, Georgia.
Apex.AI
Series B in 2021
Apex.AI, Inc. is a software company that focuses on developing solutions for autonomous mobility systems, particularly self-driving vehicles. Founded in 2017 and based in Palo Alto, California, the company offers Apex.OS, a software framework that simplifies the complexity of hardware and software integration through user-friendly APIs. Additionally, Apex.AI provides Apex.Autonomy, which is tailored for safety-critical applications, and MARV.Automotive, a versatile data management platform that facilitates data transfer between vehicles and the cloud. This platform allows for advanced analytics, data introspection, and team collaboration. Apex.AI's software products leverage open-source technologies, enabling developers to create secure and efficient applications for autonomous vehicles.
Edge Impulse
Series B in 2021
Edge Impulse is a software platform that facilitates the development of machine learning models optimized for edge devices, where data is collected either with or without connectivity. The platform streamlines the entire process of building, deploying, and scaling embedded machine learning applications, enabling developers to create intelligent devices. It supports the collection of real sensor data and incorporates live signal processing, allowing for the transformation of raw data into neural networks. Additionally, Edge Impulse offers capabilities for model testing and deployment to a variety of target devices, from microcontrollers to CPUs and GPUs, making it easier and faster for developers to manage machine learning applications for the edge.
Sounding Board
Series B in 2021
Sounding Board is a coaching management platform that assists enterprises in enhancing their leadership capabilities through a combination of one-on-one coaching and advanced technology. Founded in 2016 and headquartered in Foster City, California, the company provides a comprehensive software solution that enables organizations to implement coaching initiatives on a large scale. Its platform features personalized development plans tailored to individual learning styles, along with automation tools that simplify administration. Additionally, Sounding Board offers a high-quality network of coaches available for on-demand needs, and robust data visualization tools to assess the overall impact of coaching across the organization. Serving clients in 11 countries, the company has achieved a notable Net Promoter Score, reflecting its commitment to fostering productive leadership and managerial behaviors that drive positive business outcomes.
Reibus
Series B in 2021
Reibus operates an online marketplace that facilitates the buying and selling of metals, serving businesses in industrial markets. The platform connects buyers with a wide network of metal suppliers and provides logistics support to ensure efficient transportation of materials. Reibus emphasizes features such as anonymous buying and real-time leads for sellers, promoting a transparent and streamlined transaction process. By offering a proprietary search tool and a simplified materials listing process, the company aims to maximize price performance, reduce time to market, and lower sales and marketing expenses for its users.
Clutch
Series B in 2021
Clutch is a technology company focused on transforming the car buying process by offering a fully online platform for purchasing high-quality certified vehicles. Customers can browse a diverse inventory of second-hand cars at competitive prices on Clutch's website, where they can complete their purchases without the need for showrooms or commissioned salespeople. The platform simplifies the car buying experience by providing easier financing options and delivering vehicles directly to customers' homes. Clutch aims to enhance customer satisfaction by delivering an enjoyable and convenient car buying experience while also making a positive impact in the communities it serves.
TrueFort
Series B in 2021
TrueFort Inc. is a cybersecurity company based in Weehawken, New Jersey, founded in 2015. It specializes in real-time application and cloud workload protection solutions, focusing on securing critical applications and infrastructure. The company's flagship platform, Fortress, offers a unique approach to security by leveraging advanced behavioral analysis, machine intelligence, and automation. This platform supports zero trust application environments and addresses various security challenges through a unified solution that enhances visibility and protection against cyber threats. TrueFort's technology enables clients to utilize agents already deployed in their systems, facilitating seamless integration while significantly reducing risks associated with excessive trust.
Kepler
Series B in 2021
Kepler Communications Inc. specializes in satellite communications by designing, developing, and operating satellite infrastructure for space-based connectivity. The company focuses on creating a network of Low-Earth Orbit satellites that facilitate communication for various applications, including connecting space stations and devices. Its offerings include PolarConnect, which allows organizations in extreme environments to maintain global connectivity, and the Global Data Service, a high-bandwidth solution for transferring large data files from remote locations to the internet. Kepler is also developing everywhereIOT, a solution aimed at providing reliable, low-power connectivity for Internet of Things devices worldwide. Established in 2015 and headquartered in Toronto, Canada, Kepler serves diverse industries such as maritime, natural resources, research, defense, and logistics, positioning itself as a leader in addressing connectivity challenges in both terrestrial and space environments.
Archipelago
Series B in 2021
Archipelago is an AI-powered commercial property risk platform that delivers real-time visibility into how to better manage risk, improve portfolio resilience, and add value to portfolios through intelligent insurance and investment methods. Archipelago provides businesses with greater visibility into their data and greater control over their operations.
Tyra Biosciences
Series B in 2021
Tyra Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, that specializes in developing small molecule therapies for cancer treatment. Founded in 2018, the company aims to address drug resistance in cancer therapies through its proprietary SNÅP platform, which facilitates rapid and precise drug design by generating iterative molecular snapshots. Tyra is particularly focused on creating selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family, which are implicated in approximately 7% of all cancers. The company's lead product candidate, TYRA-300, specifically targets FGFR3 and is initially aimed at patients with metastatic urothelial carcinoma of the bladder and urinary tract. Through its innovative approach, Tyra Biosciences seeks to improve treatment outcomes for cancer patients by providing alternatives to existing therapies.
Axis Security
Series B in 2020
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in providing Zero Trust Network Access solutions, focusing on secure remote access to applications. The company's platform employs application isolation technology and a context-aware security approach, evaluating various factors to ensure that only authorized users can access specific resources within a network. This allows organizations to maintain control over sensitive information while enabling access for employees, partners, and other stakeholders. Through its cloud security and analytics solutions, Axis Security aims to enhance data protection and streamline secure access to business applications.
Papa
Series B in 2020
Papa, Inc. operates an online platform designed to connect college and nursing students with senior citizens in need of assistance and companionship. Founded in 2016 and headquartered in Miami, Florida, the platform facilitates a range of services including transportation for medical appointments, grocery shopping, house chores, technology assistance, and caregiving. By enabling older adults to access support from vetted companions, Papa helps them maintain their independence and enhances their quality of life while living at home. The platform not only addresses the practical needs of seniors but also fosters social connections, ensuring they receive both functional assistance and companionship.
Instrumental
Series B in 2020
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to autonomously operate, learn, and adapt. This innovative approach significantly reduces scrap and rework costs for manufacturers, allowing them to address issues promptly and maintain higher production yields. The company's solutions are implemented in various global assembly lines, particularly among leading manufacturers. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, Instrumental aims to revolutionize the manufacturing industry by transforming inefficiencies into opportunities. In addition to its software offerings, Instrumental provides a range of services including performance analysis, architecture and design, and management consulting, catering to both commercial clients and government agencies. Based in Saint Paul, Minnesota, Instrumental has been active since 1991, focusing on creating impactful technological advancements in data-intensive environments.
READY Robotics
Series B in 2020
READY Robotics Corp., founded in 2016 and headquartered in Baltimore, Maryland, specializes in developing ForgeOS, an innovative industrial operating system designed for robotics and automation. This platform utilizes patented technology to enable manufacturers to deploy and manage robots and automation systems through a standardized suite of low-code applications. ForgeOS is particularly suited for high-mix, low-volume manufacturing environments, which have traditionally posed challenges for automation. The system allows operators to control and program a wide range of robotic devices and industrial automation equipment from major brands through a single interface, minimizing the need for extensive training. By connecting to hundreds of robot models and thousands of industrial devices, READY Robotics enhances productivity and streamlines operations in complex manufacturing settings.
Berkshire Grey
Series B in 2020
Berkshire Grey develops a materials handling system intended to automate omnichannel fulfillment. Its system utilizes artificial intelligence, computer vision, machine learning, and novel sensing to deploy intelligent robotic systems that automate tasks never before performed by machines in commercial settings, enabling customers to achieve higher accuracy and throughput speeds than traditional approaches as well as handle the broadest assortment of products, packaging, and parcels with ease.
Capella Space
Series B in 2019
Capella Space is a commercial satellite imaging company based in San Francisco, California, founded in 2016. It operates a constellation of small satellites equipped with synthetic aperture radar (SAR) technology, capable of providing high-resolution Earth observation imagery at 50 centimeters. This technology allows for continuous monitoring of the Earth's surface, regardless of weather conditions, including clouds, smoke, and darkness. Capella Space's services support various industries, including maritime domain awareness, agriculture, infrastructure monitoring, and disaster response. The company aims to enhance decision-making related to commerce, conservation, and security by delivering timely and flexible geospatial data. Its capabilities are particularly valuable for applications involving economic activity estimation, urban planning, and search and rescue operations.
nTopology
Series B in 2019
nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.
Gen.G esports
Series B in 2019
Established in 2017, Gen.G is the leading esports organization connecting the U.S. and Asia. Ranked #6 in the 2019 Forbes list of the world’s most valuable esports companies, Gen.G is the only major organization that owns and operates top teams in the world’s leading esports markets -- China, South Korea, and the United States. Its unique portfolio of teams, winners of 7 global championships to date, includes the Seoul Dynasty franchise of the Overwatch League; 2014 & 2017 League of Legends world champion teams in South Korea; the world’s top all-female Fortnite team, based in Los Angeles; and the NBA 2K League’s historic expansion franchise in Shanghai. Gen.G’s core mission is to help fans and athletes use the power of gaming and esports to get ahead in and beyond competition. The company has quickly become a commercial and thought leader, building a global, inclusive, and cross-cultural future for sports entertainment. Its widely acclaimed initiatives include: #TeamBumble, the leading team platform for the empowerment of women in gaming; and Gen.G Elite Esports Academy, the world’s first fully-integrated academic esports program. Gen.G’s teams, content creators, and corporate staff work out of their offices in Los Angeles, Seoul, and Shanghai.
Roman
Series B in 2019
Roman is a men's health company that offers online diagnosis and discreet shipping of safe erectile dysfunctional medication. The company was launched in 2017 as a vertical of Ro, a healthcare technology company.
ScaleFactor
Series B in 2019
ScaleFactor provides accounting and finance software with automated bookkeeping, proactive alerts, and other features. It is a smart accounting and finance software that changes the way modern businesses operate. By automating complex accounting tasks and translating financial information into usable business insights, ScaleFactor is enabling business owners, managers, and entrepreneurs to focus on what they love: running and growing their business. The company was founded in 2014 and is headquartered in Austin, Texas.
Embroker
Series B in 2018
Embroker is the easiest way to intelligently ensure any business. By pairing technology and broker expertise, Embroker helps growing businesses save time and find the best value on the right coverage. As the leading digital insurance brokerage, Embroker is working to massively improve the $800 billion property and casualty (P&C) insurance market. Headquartered in San Francisco, we have offices in Chicago and Boston and customers in all 50 states.
Dragos
Series B in 2018
Dragos is an industrial cybersecurity company focused on protecting critical infrastructure to safeguard civilization. It develops software that offers essential visibility into industrial control systems (ICS) and operational technology (OT) networks, allowing for the early identification and resolution of potential threats. The software is designed to support emerging applications such as the Industrial Internet of Things (IIoT), catering to clients in sectors including power and water utilities, energy, and manufacturing. By enhancing security measures, Dragos enables these industries to establish a resilient and adaptable security posture against evolving cyber threats.
OncoResponse
Series B in 2018
OncoResponse Inc. is a Houston-based immuno-oncology company focused on discovering innovative cancer therapies through its proprietary human antibody platform. The company specializes in identifying fully human monoclonal antibodies that target high-value immuno-oncology targets, particularly those associated with immunosuppressive myeloid biology. By exploring the adaptive immune responses of cancer patients who have successfully undergone checkpoint inhibition, OncoResponse aims to develop therapeutic antibodies that can mitigate tumor microenvironment immunosuppression and enhance immune activation. This approach seeks to transform cold tumors into hot tumors, thereby improving treatment outcomes for cancer patients.
Cargomatic
Series B in 2018
Cargomatic, Inc. operates an online platform that connects shippers with pre-screened and qualified carriers in real-time, primarily serving the Southern California region. Established in 2013 and based in Venice, California, Cargomatic has developed a technology-driven network for local truck availability. Shippers can submit loads and quickly find nearby trucks to meet their logistics needs. Since its launch in early 2014, the platform has facilitated tens of thousands of deliveries across California, Chicago, and metropolitan New York. By streamlining the booking process and providing real-time tracking capabilities, Cargomatic enhances service levels, improves pick-up and delivery rates, and allows customers to manage outsourced vendors efficiently. The company operates as a subsidiary of Genesee & Wyoming Inc.
Kustomer
Series B in 2018
Kustomer, Inc. is a customer service software company that specializes in developing a customer relationship management (CRM) platform designed to enhance customer interactions and support. Founded in 2015 and headquartered in New York, with an additional office in Durham, North Carolina, Kustomer's platform consolidates data from various sources, allowing businesses to manage customer inquiries effectively. It provides agents with access to comprehensive customer information, including buying history and previous conversations, facilitating a seamless service experience. The platform is utilized by leading brands in customer service, enabling them to deliver personalized support through a unified timeline view. Kustomer's focus on proactive customer service solutions positions it as a key player in the evolving landscape of enterprise customer support.
Mynd
Series B in 2018
Mynd is a technology-driven property management firm that specializes in managing single-family rental properties. The company is dedicated to helping property owners optimize their real estate investments through a comprehensive suite of services, which includes property marketing, tenant screening, rent collection, property maintenance, and accounting. By focusing on the rental sector, Mynd aims to simplify the property management process, reducing the everyday burdens faced by landlords while maximizing their investment returns. The firm leverages technology and data analytics to improve property performance and ensure effective communication with clients. Property owners benefit from access to financial reports and real-time updates, enabling them to make informed decisions about their investments through Mynd's digital platforms.
Vineti
Series B in 2018
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.
IDEAYA Biosciences
Series B in 2018
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enhancing immunotherapy response, and immuno-oncology therapies targeting the tumor micro-environment. IDEAYA, located in South San Francisco and La Jolla, California, has assembled leading scientists and advisors with extensive knowledge and expertise in cancer biology and small molecule drug discovery.
Imanis Data
Series B in 2018
Imanis Data, based in San Jose, California, specializes in subscription-based data availability management solutions designed for large-scale enterprises. The company's flagship product, FastFind, is a metadata catalog that enhances Big Data applications, facilitating management across various platforms such as Cassandra and Hive through an intuitive graphical interface. This solution allows users to implement role-based access control, enable self-service access, and monitor analytics related to data consumption and system health. Additionally, Imanis Data offers a backup and recovery platform that proactively detects ransomware attacks and identifies potential data loss. Formerly known as Talena, Imanis Data was incorporated in 2012 and operates as a subsidiary of Cohesity. The company is focused on leveraging advanced technologies to provide robust and scalable data management solutions, ensuring data resiliency for petabyte-scale data sets, whether stored on-premises or in the cloud.
Contentsquare
Series B in 2018
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.
Ladder
Series B in 2018
Ladder is a digital life insurance company founded in 2015 and headquartered in Palo Alto, California. It provides flexible term life insurance coverage that can be obtained quickly and efficiently, allowing policyholders to save up to 40%. The company employs an all-digital architecture and real-time underwriting, which simplifies the life insurance application process by eliminating the need for commissioned sales agents. This approach enables financially savvy consumers to apply for insurance online without the need for in-person meetings. Ladder offers coverage options up to $8 million and operates across all 50 states, making life insurance more accessible and affordable for a wide range of individuals.
MindTickle
Series B in 2017
MindTickle is a privately-held company that provides a data-driven sales readiness platform aimed at enhancing the effectiveness of customer-facing teams. With its headquarters in San Francisco and Pune, the platform is utilized by sales teams across various industries to address knowledge and skill gaps through automated training paths, adaptive learning, and virtual coaching tools. MindTickle's solution incorporates gamification and role-play elements, facilitating on-demand training and mobile updates. This comprehensive approach helps organizations assess and certify the readiness of their sales representatives, leading to improved deal sizes, higher win rates, and shorter sales cycles. Investors in MindTickle include Accel, Canaan, NEA, NewView Capital, Norwest Venture Partners, and Softbank.
PerimeterX
Series B in 2017
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
Vivace Therapeutics
Series B in 2017
Vivace Therapeutics, Inc. is a drug discovery and development company focused on creating cancer therapies that target the Hippo pathway, which plays a crucial role in tissue regeneration and organ development. Established in 2014 and located in the San Francisco Bay Area, Vivace Therapeutics employs an innovative approach to develop small molecule treatments aimed at improving patient outcomes in oncology. The company collaborates with leading academic institutions to advance research and develop therapies that can be used alone or in combination with existing treatments. With a commitment to enhancing cancer care, Vivace Therapeutics is dedicated to delivering novel solutions that can help patients combat cancer more effectively.
Iterum Therapeutics
Series B in 2017
Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing anti-infective therapies to address multi-drug resistant pathogens. Headquartered in Dublin, Ireland, the company is advancing its lead product, sulopenem, a novel penem compound available in both oral and intravenous formulations. Currently in Phase III clinical trials, sulopenem is being evaluated for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum aims to provide effective solutions to combat antibiotic resistance, particularly against a range of gram-negative, gram-positive, and anaerobic bacteria that are resistant to existing antibiotics. Founded in 2015, Iterum Therapeutics seeks to improve the lives of patients affected by serious and life-threatening infections globally.
Onkos Surgical
Series B in 2017
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing innovative technologies and solutions for surgical oncologists. Founded in 2014, the company specializes in addressing the challenges of musculoskeletal cancers and complex orthopedic conditions. Its offerings include GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. Onkos Surgical emphasizes a personalized approach, utilizing advancements in virtual surgical planning, 3D modeling and printing, and implant design to enhance patient outcomes and experiences. By leveraging expertise in patient imaging analysis and workflow optimization, Onkos Surgical aims to simplify surgical processes and improve the effectiveness of tumor surgeries.
UNIFi Software
Series B in 2017
Unifi Software, Inc. specializes in developing self-service data integration tools designed for both business users and IT professionals. Its primary products include the Unifi catalog, which leverages AI technology for data crawling and asset collection, facilitating the identification and processing of critical data assets while offering features such as user-friendly search, collaboration, and data governance. The company also offers the Unifi data platform, which aids business analysts in data acquisition, discovery, transformation, and management of unstructured data, while providing IT professionals with tools for user authorization and resource management. Available through the Microsoft Azure Marketplace, Unifi's solutions support various applications, including audience analytics and cloud migration. Founded in 2013 and based in San Mateo, California, Unifi Software operates as a subsidiary of Boomi, Inc.
Apartment List
Series B in 2016
Apartment List, Inc. operates an online rental marketplace in the United States, facilitating connections between renters and landlords. Founded in 2008 and headquartered in San Francisco, California, the platform offers a user-friendly search experience that allows individuals to discover rental properties based on price, location, and amenities. Apartment List aims to simplify the renting process by providing a personalized and transparent experience, helping users navigate the complexities of finding a home. The platform's curated search feature is designed to understand the unique needs of each individual, making the apartment search more efficient and enjoyable. By focusing on fairness and accessibility, Apartment List seeks to enhance the overall renting experience for both tenants and property owners.
Chrono Therapeutics
Series B in 2016
Chrono Therapeutics Inc. is a pharmaceutical company based in Hayward, California, specializing in digital transdermal drug delivery systems. Founded in 2003, the company has developed SmartStop, a digital nicotine replacement therapy that incorporates a wearable device. This innovative solution allows for programmable delivery of nicotine, adjusting timing and dosage to effectively manage withdrawal symptoms and peak addiction triggers. By combining this transdermal therapy with real-time behavioral support, Chrono Therapeutics aims to enhance smoking cessation efforts and improve clinical outcomes for users. The leadership team brings extensive experience in product development, research and development, and a deep understanding of the smoking cessation market, positioning the company to play a significant role in addressing the smoking epidemic.
Rocketrip
Series B in 2016
Rocketrip, Inc. is a travel management platform that incentivizes employees to make cost-effective travel decisions for business purposes. Founded in 2013 and based in New York, the platform provides real-time insights into travel expenses, helping employees understand reasonable spending limits. By establishing a custom-calibrated Price to Beat, Rocketrip motivates employees to select lower-cost options for flights, car rentals, and hotel accommodations, thereby enabling them to earn rewards for saving the company money. The platform integrates seamlessly with existing online booking processes, ensuring minimal disruption. Rocketrip is utilized by notable enterprises such as iHeartMedia, Feld Entertainment, and Twitter, and operates as a subsidiary of Mondee Holdings Inc.
World View
Series B in 2016
World View is a pioneering company in stratospheric exploration and flight, focusing on advanced research, discovery, and human spaceflight. With over 115 successful flights, it has developed patented technologies for innovative takeoff, landing systems, and trajectory control in the stratosphere. The company's offerings include Stratollites, which provide persistent imaging and data collection over specific areas for extended periods, serving as an affordable alternative to satellites and drones. World View's expertise has garnered the trust of NASA and various governmental and scientific organizations, enabling it to deliver high-resolution data and analytics for diverse applications. Additionally, the company is expanding into space tourism, aiming to make edge-of-space travel accessible to the public. Through these initiatives, World View aspires to inspire and explore new perspectives for a better future.
Tizona Therapeutics
Series B in 2016
The company is establishing collaborations with its scientific founders “to better understand whether regulatory T cells play a more prominent role in certain tumors,” he added. Although research suggests that Tregs cells play a more prominent role in creating immunosuppression in the microenvironment in some tumor types than others, “quite honestly, the data are lacking. One of the ways we’re going to differentiate the company is to understand that relationship better.
Unchained Labs
Series B in 2016
Unchained Labs is a developer of life science biologics tools designed to help researchers break free from tools that just don't cut it. It offers a multiplex protein stability platform for biologics that measures a host of protein stability parameters. The company's products include protein sizing systems, stability quantifiers, benchtop workflow solutions, automated buffer exchanges, concentration liberators, particle identifiers, and more, enabling biologics researchers to speed up their work with ease. Unchained Labs was established in 2013 and is based in Pleasanton, California, USA.
Bellhop
Series B in 2015
Bellhops, Inc. is a moving services company based in Chattanooga, Tennessee, founded in 2013. It specializes in providing truck, trailer, storage unit, and mobile storage container loading and unloading services, along with heavy lifting assistance. The company employs a technology-driven model that connects athletic students with individuals and businesses requiring moving help, facilitating both local and long-distance moves in 55 cities across the United States. By offering an online platform for booking services, Bellhop aims to enhance the customer experience, providing a transparent review system and a personal dashboard for users to manage their moving process. The company focuses on delivering cost-effective solutions while addressing the needs of small and medium-scale moves.
Arvinas
Series B in 2015
Arvinas, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in the discovery, development, and commercialization of therapies designed to degrade disease-causing proteins. The company’s lead product candidates include ARV-110, a proteolysis-targeting chimera (PROTAC) currently in phase I clinical trials for treating metastatic castration-resistant prostate cancer, and ARV-471, which targets the estrogen receptor for patients with metastatic ER-positive/HER2-negative breast cancer. Additionally, Arvinas is developing other PROTACs aimed at degrading various androgen receptor mutations and has initiatives focused on treating neurodegenerative diseases, including tauopathies. Arvinas collaborates with major pharmaceutical companies such as Pfizer, Genentech, Roche, and Bayer to advance its innovative therapeutic approaches. Founded in 2015, Arvinas is dedicated to improving the lives of patients with debilitating and life-threatening conditions through its unique protein degradation technology.
Antiva Biosciences
Series B in 2015
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.
RealtyMogul
Series B in 2015
RealtyMogul is an online marketplace that facilitates real estate investing by connecting investors with institutional-quality real estate opportunities. Founded in 2012 by Jilliene Helman and Justin Hughes, the company is headquartered in Los Angeles, California. The platform allows investors to browse various real estate investments, review due diligence materials, and securely sign legal documents online. It aims to simplify the investment process by providing access to well-leased properties, all managed by registered broker-dealers. Investors can monitor their investments through a dedicated dashboard, offering 24/7 visibility into their financial engagement. This approach reduces both the time and costs typically associated with real estate investing while aiming to decrease risk for individual and institutional investors alike.
Tubular Labs
Series B in 2015
Tubular Labs is a leading video measurement and analytics platform that serves broadcasters, publishers, and brands by providing insights into video consumption patterns. The platform tracks over 4 billion videos and 1 trillion views, analyzing a vast array of data that includes 10 million influencers and 90,000 brands. It offers a comprehensive view of the social video ecosystem, allowing businesses to create effective content and scale their audiences more rapidly. Tubular Labs delivers valuable ratings and context for digital video, helping companies refine their content strategies, enhance distribution, and optimize paid media campaigns. The platform is trusted by several top global media companies, who rely on its analytics to make informed strategic decisions in the dynamic landscape of video content.
Glooko
Series B in 2015
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Beckon
Series B in 2015
Beckon, Inc. offers omnichannel analytics software designed to provide marketers with performance analytics, visualization, and reporting solutions. Founded in 2011 and based in San Mateo, California, the company operates as a subsidiary of Aclate, Inc. Beckon's software-as-a-service platform integrates marketing data to deliver dashboards and scorecards that facilitate cross-channel marketing intelligence. The platform emphasizes data management and visibility into marketing performance, enabling users to analyze their campaigns in real time. It provides automated tools for campaign planning and offers key performance indicators to help marketers optimize their strategies, maximize return on investment, and demonstrate the impact of marketing efforts on overall business outcomes.
ALDEA Pharmaceuticals
Series B in 2014
ALDEA Pharmaceuticals, Inc. is focused on developing small-molecule modulators of the aldehyde dehydrogenase (ALDH) enzyme family to address diseases related to toxic aldehyde accumulation. The company’s innovative technology aims to provide new treatment options across various therapeutic areas, particularly for conditions associated with aldehyde metabolism dysfunction, such as acute alcohol toxicity and rare diseases like Fanconi anemia. One of the key compounds being developed enhances the detoxification of acetaldehyde, which may alleviate acute symptoms and mitigate long-term tissue damage and cancer risk. Founded in 2008 and based in Redwood City, California, ALDEA Pharmaceuticals is working to advance its proprietary solutions to tackle unmet medical needs.
Turo
Series B in 2014
Turo Inc. operates an online peer-to-peer car rental marketplace that connects local car owners with travelers seeking to rent vehicles. Founded in 2009 and based in San Francisco, California, the platform allows owners to list their cars for rent, offering a diverse selection of vehicles at competitive prices. Travelers can choose from various options for local pickup, city delivery, and airport delivery. This model not only provides convenient access to cars for renters but also enables owners to generate income from their vehicles. Turo aims to create a community of trusted hosts and guests, facilitating a seamless car-sharing experience.
Instacart
Series B in 2014
Instacart is a prominent grocery delivery service operating in the United States and Canada, facilitating rapid deliveries of groceries and home essentials, often within an hour. The company partners with a variety of local and national grocers, including well-known brands such as Safeway, Whole Foods, and Costco, allowing customers to select from over 500,000 items and combine orders from multiple stores. Instacart employs a network of approximately 600,000 independent contractors who pick and deliver items directly to customers' homes. In addition to its delivery services, Instacart generates revenue by charging fees based on order value and by offering advertising opportunities primarily to consumer-packaged goods companies. With nearly 8 million monthly active users, Instacart has established itself as a leading platform in the grocery delivery market.
Tubular Labs
Series B in 2014
Tubular Labs is a leading video measurement and analytics platform that serves broadcasters, publishers, and brands by providing insights into video consumption patterns. The platform tracks over 4 billion videos and 1 trillion views, analyzing a vast array of data that includes 10 million influencers and 90,000 brands. It offers a comprehensive view of the social video ecosystem, allowing businesses to create effective content and scale their audiences more rapidly. Tubular Labs delivers valuable ratings and context for digital video, helping companies refine their content strategies, enhance distribution, and optimize paid media campaigns. The platform is trusted by several top global media companies, who rely on its analytics to make informed strategic decisions in the dynamic landscape of video content.
CircleUp
Series B in 2014
CircleUp Network, Inc. operates an equity crowdfunding platform that connects entrepreneurs in the consumer and retail sectors with accredited investors. Established in 2011 and based in San Francisco, CircleUp facilitates access to capital and resources for early-stage brands by posting detailed profiles of promising companies on its platform. This allows investors to discover, research, and invest in innovative consumer businesses. The company utilizes its proprietary machine learning platform, Helio, which analyzes vast amounts of data to evaluate a large number of consumer businesses and predict their future success. Through this modern approach, CircleUp aims to streamline the investment process in private markets, fostering growth for emerging brands.
UrbanSitter
Series B in 2014
UrbanSitter, Inc. is a childcare marketplace that connects parents with babysitters and nannies through shared connections. Founded in 2010 and based in San Francisco, the company operates in major cities including New York City, Chicago, Los Angeles, Seattle, Washington D.C., Boston, Denver, and San Diego. UrbanSitter offers an app and website that simplifies the process of finding, booking, and paying for trusted care across various needs, including child care, senior care, pet sitting, and household services. By leveraging a parent's personal network, UrbanSitter helps families find caregivers recommended by friends, co-workers, and local parents, ensuring a level of trust and reliability. The platform is particularly useful for last-minute childcare needs, boasting average response times of under three minutes. By addressing the challenges of securing reliable care, UrbanSitter provides families with essential support in their daily lives.
SureWaves
Series B in 2014
SureWaves MediaTech Private Limited, founded in 2006 and headquartered in Bengaluru, India, provides innovative media convergence solutions aimed at transforming television advertising. The company operates Skynet, a programmatic advertising marketplace that allows marketers to efficiently plan and purchase audience-targeted ads on broadcast TV. Additionally, SureWaves Spot TV Network enables brands to connect with diverse audiences through local cable and regional satellite channels. The organization is leveraging advances in cloud computing to develop the SureWaves Media Grid, an integrated platform for ad aggregation, content delivery, and media management. With a leadership team comprised of experienced professionals from various sectors, SureWaves has filed over 40 patents related to its technology. The company has successfully entered the digital out-of-home market and expanded its services to local television advertising, making advertising more accessible and measurable for clients.
India Property Online
Series B in 2013
IndiaProperty.com provides in-depth information on buying, selling and renting out properties in India. It has partnered with leading media organisations to provide prompt and reliable service to customers through various channels and to enhance better visibility and increase responses. IndiaProperty.com is a part of Consim Info Pvt. Ltd, India's leading Internet company. Consim is Red Herring's Global 100 Winner, and also majors in other verticals like Matrimony, Jobs and Classifieds.
Corvium
Series B in 2013
Corvium is a food intelligence company that develops food safety software designing and analysis solutions. It offers floor plans, scheduling, test data management, corrective actions, and seamless reporting solutions. The company CONTROL-PRO workflow solution reduces food safety risk by accelerating the EMP testing lifecycle and eliminating repetitive error-prone manual tasks that lead to unplanned adverse financial outcomes such as undetected contamination and recalls. CONTROL-PRO enables continuous visualization, monitoring, analytics, and up-to-date documentation of food safety testing across multiple production facilities. Corvium delivers data, insights, and superior customer service to ensure that clients' products are safe. The INSIGHTS food intelligence solution works hand in hand with CONTROL-PRO to aggregate and visualizes all relevant internal and external data, while continuously monitoring data flows and providing tailor-made and up-to-date analysis of food safety performance across multiple production facilities.
Sample6
Series B in 2013
Sample6 is a synthetic-biology based bacteria diagnostic system capable of enrichment-free detection. Its technology detects as low as 1CFU/ml in just 4 hours. Its proprietary Bioillumination Platform was developed by Professor Tim Lu (MIT) and Dr. Michael Koeris in the lab of Professor James Collins at the Howard Hughes Medical Institute and Boston University. The platform allows for the engineering of bioparticles that target and “light up” specific unwanted bacteria—or specific groups of bacterial species. They couple this capability with highly sensitive sensor technology that detects low levels of pathogens to see results in minutes—right on-site—with no laboratory required. Sample6′s mission is to improve the health and safety of global consumers by building integrated systems that quickly and easily detect harmful and unwanted bacteria. They see applications in food production, retailing, healthcare, and beyond—anywhere humans and bacteria intersect.
JOOR
Series B in 2013
JOOR, Inc. operates an online global fashion marketplace that facilitates wholesale buying by connecting brands and retailers. Founded in 2010 and headquartered in New York, the company also has offices in Los Angeles, London, Milan, Paris, Sydney, and Melbourne. JOOR aims to enhance the wholesale purchasing process by digitizing and streamlining operations, thereby eliminating manual tasks that are often time-consuming and prone to errors. This digital platform not only allows brands and retailers to increase revenue and reduce costs but also enhances customer experience and enables performance monitoring through data analytics. Additionally, JOOR has established a strategic partnership with ORDRE to further its mission in the fashion industry.
Minimally invasive devices
Series B in 2013
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.
Dermira
Series B in 2013
Dermira, Inc. is a biopharmaceutical company based in Menlo Park, California, that focuses on developing and commercializing therapies for dermatologic conditions in the United States. The company offers QBREXZA, a once-daily topical treatment for primary axillary hyperhidrosis in patients aged nine years and older. Additionally, Dermira is advancing several product candidates, including lebrikizumab, a monoclonal antibody currently in Phase IIb trials for moderate-to-severe atopic dermatitis, and glycopyrronium tosylate, which is in Phase III trials for hyperhidrosis. Dermira also has collaborations with other companies for the development and commercialization of its products, such as a partnership with UCB Pharma for Cimzia, aimed at treating chronic plaque psoriasis. Founded in 2010, Dermira aims to provide innovative solutions for dermatologists and their patients.
WibiData
Series B in 2013
WibiData is a software company that provides big data applications for enterprises to deliver personalized experiences across channels. Its platform is built on open-source technologies Apache Hadoop, Apache Cassandra, Apache HBase, Apache Avro and the Kiji Project. WibiData was founded under the name Odiago in 2010 by Christophe Bisciglia, Aaron Kimball and Garrett Wu. Based in San Francisco, Calif., WibiData is backed by Canaan Partners, New Enterprise Associates, SV Angel and several notable seed investors. For more information, visit www.wibidata.com.
The RealReal
Series B in 2013
The RealReal operates as the largest online marketplace for authenticated, resale luxury goods, specializing in various categories such as fashion for women, men, and children, as well as jewelry, watches, home items, and art. Founded in 2011 and headquartered in San Francisco, the company boasts over 37 million members and has sold nearly 40 million items through its platform. The RealReal employs a rigorous authentication process managed by in-house experts, including gemologists and horologists, ensuring the reliability of its offerings. As a sustainable business, it promotes the circular economy by giving new life to luxury items from numerous brands. The company simplifies the selling process for consignors with services such as virtual appointments, in-home pickups, and direct shipping, while managing all aspects of the transaction, from pricing and listing to shipping and customer service. In 2023, The RealReal generated significant gross merchandise volume, capitalizing on a market previously underserved by traditional retail outlets.
Minimally invasive devices
Series B in 2013
MID has developed the FloShield system, a franchise of products that substantially improve visualization during laparoscopic surgery. During laparoscopic surgery, it is common for condensation to form on the end of the laparoscope obscuring vision. It is also common for debris from the ultrasonic scalpel, cautery, or even blood products themselves to degrade the surgical view. Most commonly, surgeons will need to remove the laparoscope for manual cleaning. It was founded in 2006 and headquartered in Columbus, Ohio.
Theraclone Sciences
Series B in 2013
Theraclone Sciences (formerly Spaltudaq) is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company's technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for large-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.
Artspace
Series B in 2013
Artspace is the premier online retailer where collectors can purchase works by top contemporary artists directly from leading commercial galleries, prestigious cultural institutions, and non-profits. Our curators also commission works directly from the most renowned artists working today, working closely with their studios to produce exclusive limited editions. Our mission is to help both aspiring and experienced collectors discover, learn about, and acquire art while helping artists and the institutions that support them reach broader audiences worldwide. Proceeds from many of the works on our site benefit these esteemed institutions and artists.
Shopkeep
Series B in 2012
Shopkeep Inc. is a provider of cloud-based point of sale (POS) solutions tailored for small and medium-sized businesses (SMBs). Founded in 2008 and headquartered in New York City, with additional offices in Portland, Northbrook, and Belfast, the company offers a comprehensive suite of services including POS hardware, mobile payment processing, inventory management, and customer tracking. Its intuitive iPad-based system features point-to-point encryption and supports various payment methods, including EMV and NFC for mobile payments. Shopkeep also provides a merchant cash advance service, robust reporting and analytics, and a marketing dashboard to enhance customer engagement. With over 25,000 clients across various sectors, including retail and food services, Shopkeep aims to empower independent business owners by streamlining operations and providing real-time insights. The company is recognized for its award-winning 24/7 customer support, ensuring that users can effectively manage their businesses. As of November 2020, Shopkeep operates as a subsidiary of Lightspeed POS Inc.
CytomX Therapeutics
Series B in 2012
CytomX Therapeutics is an oncology-focused biopharmaceutical company based in South San Francisco, California. The company specializes in developing proteolytically-activated antibody therapeutics using its proprietary Probody technology platform. This innovative approach aims to create cancer immunotherapies that enhance targeting of tumor cells while minimizing effects on healthy tissues. CytomX's clinical-stage product candidates include CX-072, which targets programmed cell death ligand 1; CX-2009, a drug conjugate against CD166; and BMS-986249, a CTLA-4 Probody therapeutic for metastatic melanoma, among others. The company has established strategic collaborations with several major pharmaceutical companies, including AbbVie, Amgen, and Bristol-Myers Squibb, to further the development of its Probody therapeutics. Founded in 2008, CytomX is dedicated to providing patients with more effective and less toxic treatment options for cancer and inflammatory diseases.
Ambra Health
Series B in 2012
Ambra Health is a medical data and image management company that provides a cloud-based platform designed to enhance the accessibility and management of medical images. The platform is intuitive, flexible, and scalable, enabling healthcare providers, including prominent health systems and clinical research organizations, to improve their imaging workflows and collaborative care. By offering secure and straightforward access to medical images, Ambra Health facilitates better internal adoption and collaboration among healthcare professionals. This capability allows organizations to significantly enhance their operational efficiency and patient care outcomes by making medical images and data accessible from anywhere.
SilverRail
Series B in 2012
SilverRail is an information technology company based in London, England, that focuses on passenger rail ticketing and travel distribution technology. Founded in 2009, SilverRail has developed a unified digital infrastructure platform designed specifically for the rail industry. This platform connects carriers and suppliers with both online and offline travel distributors, enhancing the customer experience through a comprehensive suite of services. These services include journey planning, inventory management, scheduling, pricing, booking, payment, ticketing, reporting, and administration. SilverRail aims to provide passengers with easy and efficient access to global rail content.
Transcend Medical
Series B in 2012
Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70 million worldwide by the year 2015. In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.